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hepatitis C disease progression; however, the mechanism underlying this effect is unknown. Here,
we investigated the role of HIV-1 in HCV gene expression and the mechanism involved in this reg-
ulation. We discovered that HIV-1 Rev protein activates HCV gene expression. We further revealed
that Rev binds to the internal loop of the HCV 50-untranslated region (50-UTR) to stimulate HCV
IRES-mediated translation.
 2011 Federation of European Biochemical Societies. Published by Elsevier B.V.1. Introduction other cellular proteins (e.g., DDX3, PIMT, and Matrin 3) are directlyDue to the shared routes of transmission, infection with hepati-
tis C virus (HCV) is common among human immunodeﬁciency
virus-1 (HIV-1)-infected patients. Infection with HIV-1 may
enhance HCV replication since HCV RNA levels are signiﬁcantly
elevated in coinfected patients [1]. Also, HIV-1 seroconversion is
associated with sustained increases in HCV viral load [2]. A conve-
nient experimental system for studying the direct interactions
between HIV-1 and HCV in a coinfection system is not yet avail-
able. However, HIV-1 may adapt to and efﬁciently replicate in
hepatocytes and hepatic stellate cells [3,4]. HCV replication also
occurs in extra-hepatic reservoirs, including peripheral blood
mononuclear cells (PBMCs) and native human macrophages [5,6].
These reports demonstrate that the two viruses may reside, repli-
cate, and interact in the same cells.
Rev is an essential regulatory protein that is crucial in the life cy-
cle of HIV-1. Rev binds to a speciﬁc RNA secondary structure known
as the Rev-responsive element (RRE), which is present in unspliced
or partially spliced viral RNA. The Rev-RRE complex associates with
CRM1 to shuttle from the nucleus into the cytoplasm [7]. Severalal Societies. Published by Elsevier
of Virology, College of Life
ax: +86 27 68754592.involved in this process [8–10]. Besides its nuclear export function,
Rev has additional, independent stimulatory effects, including the
promotion of translation [11].
The HCV 50-UTR encompasses four structural domains (domains
I–IV) (Fig. 1A). Domains II–IV comprise an internal ribosome entry
site (IRES) that mediates translation of the HCV open reading frame
(ORF). Translation of the HCV ORF is initiated by a 50 cap-indepen-
dent mechanism at the HCV IRES [12]. First, the ribosomal 40S
subunit binds speciﬁcally to the HCV IRES. Next, eukaryotic trans-
lation initiation factor 3 (eIF3) is recruited to form the 43S pre-ini-
tiation complex. Finally, the ribosomal 60S subunit associates with
the 43S pre-initiation complex to form the 80S ribosome [13]. In
this study, we show for the ﬁrst time that Rev binds to the HCV
50-UTR, enhancing HCV IRES-mediated translation and up-regulat-
ing HCV gene expression.2. Materials and methods
2.1. Cell culture and transfection
Huh7.5.1 [14] cells were cultured in Dulbecco’s Modiﬁed Eagle’s
Medium (Gibco BRL, Grand Island, NY, USA) supplemented with
10% fetal calf serum (Gibco BRL), 100 U/ml penicillin, and 100 lg/B.V. Open access under CC BY-NC-ND license.
Fig. 1. RNA secondary structure. (A) Schematic diagram of the secondary structure of the RNA 50-end (nt 1–388) of HCV strain JFH1 genotype 2a, which refers to ‘‘full-length
HCV IRES RNA.’’ Nucleotides 1–340 correspond to the ‘‘HCV 50-UTR.’’ Internal loop IIIb is boxed. The mutations in the HCV 50-UTR used in this study are indicated. (B)
Schematic diagram of the secondary structure of loop IIIb in the HCV 50-UTR, internal loop in the HIV-1 RRE, and loop A in HIV-1 50-UTR. Abbreviation: del, deletion.
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24-well plates one day prior to transfection using Lipofectamine
2000 (Invitrogen, Carlsbad, CA, USA).
2.2. Plasmid construction
Plasmid FL-J6/JFH-50C19Rluc2Aubi is a monocistronic full-
length HCV genome derived from the previously reported infec-
tious genotype 2a HCV genome J6/JFH1 that expresses Renilla
luciferase [15]. This plasmid was kindly provided by Dr. Charles
M. Rice [16]. The HIV-1 Rev gene was ampliﬁed by PCR from
PNL4-3, an infectious molecular clone of HIV-1 [17], then inserted
into the vector pCMV-Tag 2B. Two mutated Rev genes, Rev-M6 and
Rev-M10 [18], were constructed by PCR-based site-directed muta-
genesis using the plasmid pCMV-Tag2B-Rev as template, theninserted into pCMV-Tag 2B. In Rev-M6, four amino acid residues
(R41, R42, R43, and R44) were substituted with aspartic acid
(Asp) and leucine (Leu), resulting in a two amino acid deletion. In
Rev-M10, two amino acid residues (L78 and E79) were substituted
with Asp and Leu. The coding sequences of Rev, Rev-M6, and Rev-
M10 were subcloned into the bacterial expression vector pET-28a.
The monocistronic reporter plasmid pHCV50 + 30 was then
constructed. It contained the following elements in a 50 to 30 order
in the vector PMD18-T Simple (Takara, Shiga, Japan): T7 promoter,
the complete 50-UTR (nucleotides [nt] 1–340) plus a 25 amino acid
core protein-encoding sequence from strain HCV-2a, ubiquitin, the
ﬁreﬂy luciferase (FLuc) gene, and the entire HCV 30-UTR.
All DNA used for the in vitro transcription of HIV RNA was de-
rived from the plasmid PNL4-3 by PCR. The DNA used for the
in vitro transcription of green ﬂuorescent protein (GFP) mRNA
4004 J. Qu et al. / FEBS Letters 585 (2011) 4002–4009was generated from the plasmid peGFP-C1 by PCR. All DNA used
for the in vitro transcription of HCV RNA was derived from the
plasmid pHCV50 + 30 by PCR. The DNA used for the in vitro tran-
scription of HIV REE RNA was generated from the HIV-1 Env gene
(nt 7300–7550) by PCR. The DNAs generated in these reactions
were downstream of the T7 promoter sequence.
2.3. In vitro transcription
RNA was transcribed with a MEGAscript™ T7 kit (Ambion, Aus-
tin, TX, USA) and puriﬁed with a MEGA clear kit (Ambion) accord-
ing to the manufacturer’s protocol. FL-J6/JFH-50C19Rluc2AUbi RNA
was generated essentially as described previously [16]. The RNA
probe was labeled at the 30-end using Biotin-16-UTP (Roche, Indi-
anapolis, IN, USA) and T4 RNA ligase (Promega, Madison, WI, USA)
and again puriﬁed by gel electrophoresis.
2.4. Luciferase reporter gene assay
To harvest samples for the luciferase assays, cells were washed
once with PBS, followed by the addition of 100 ll of lysis buffer
(Promega) to each well of the 24-well plate. Each sample (50 ll)
was then mixed with luciferase assay substrate (Promega). Lucifer-
ase activity was typically measured for 10 s using a luminometer.
All assays were performed in triplicate; the results are expressed
as the mean ± s.d. of luciferase activity.
2.5. In vivo immunoprecipitation assay
Huh7.5.1 cells were infected with JFH1 for four days and then
transfected with pCMV-Tag 2B-Rev. Post-transfection (48 h), the
cells were collected. In vivo immunoprecipitation assays were con-
ducted as described previously [19]. The RNA was extracted and
analyzed by RT-PCR using HCV RNA-speciﬁc primers (forward:
50-TCGTATGATACCCGATGCT-30 and reverse: 50-GTTTGACCCTTG
CTGTTGA-30).
2.6. Protein expression and puriﬁcation
The plasmids pET-28a-Rev, pET-28a-Rev-M6, and pET-28a-Rev-
M10 were transformed into Escherichia coli strain BL21. Protein
expression and puriﬁcation were conducted as described previ-
ously [20].
2.7. Native gel mobility shift assay
HCV 50-UTR RNA was renatured by incubation at 95 C for 3 min
and cooling to 25 C for 10 min. The RNA and Rev protein were
then incubated together in binding buffer (20 mM Tris–Cl [pH
7.5], 5 mM MgCl2, 50 mM KCl, 1 mM dithiothreitol, 10% glycerol,
and 2 U of RNasin) at 37C for 20 min. The samples were then
loaded onto a native 8% polyacrylamide gel and transferred to
nitrocellulose membranes (Minipore, Billerica, MA, USA). The
membranes were then blocked with 10% fat-free powdered milk
in PBST for 30 min, incubated with HRP-Streptavidin (GE) for 1 h,
washed, incubated with HRP substrate luminol reagent (Millipore),
and analyzed using a Luminescent Image Analyzer (Fujiﬁlm
LAS-4000, Tokyo, Japan).
3. Results
3.1. Rev activates HCV gene expression and interacts with HCV RNA
Huh7.5.1 cells were co-transfected with FL-J6/JFH-
50C19Rluc2AUbi RNA and the mRNA for each HIV-1 gene, respec-tively. The Renilla luciferase activity of FL-J6/JFH-50C19Rluc2Aubi
was measured 12 h post-transfection. Rev stimulated HCV gene
expression by 3.8-fold while Tat enhanced HCV gene expression
by 2.0-fold. The other HIV-1 proteins had no effect on HCV gene
expression (Fig. 2A). To conﬁrm the effect of Rev on HCV gene
expression, we constructed Rev-M6 and Rev-M10, two well-char-
acterized dominant-negative Rev mutants [18]. Huh7.5.1 cells
were co-transfected with FL-J6/JFH-50C19Rluc2AUbi RNA and
mRNA encoding Rev, Rev-M6, Rev-M10, or GFP, respectively.
Wild-type Rev activated HCV gene expression, whereas the two
mutants (Rev-M6 and Rev-M10) did not (Fig. 2B). Huh7.5.1 cells
were co-transfected with FL-J6/JFH-50C19Rluc2AUbi RNA and the
plasmid PNL4-3 or the control plasmid pUC18. The cells were
harvested and analyzed for Renilla luciferase activity at 24 h
post-transfection. We found that PNL4-3 stimulated HCV gene
expression (Fig. 2C).
We further veriﬁed the effect of Rev on JFH1 viral gene expres-
sion, a genotype 2a HCV isolate [21]. Huh7.5.1 cells were infected
with JFH1 virus and then transfected with Rev, Rev-M6, Rev-M10,
or GFP mRNA. The cells were collected and analyzed by Western
blotting. The HCV core protein level was increased in the presence
of Rev, but not in the presence of Rev-M6, Rev-M10, or GFP
(Fig. 2D).
To explore the mechanism of the activation of HCV gene expres-
sion by Rev, we investigated whether Rev interacts with HCV RNA
using an in vivo immunoprecipitation assay. An HCV-speciﬁc prod-
uct was obtained in the input and supernatant fractions of the
samples (Fig. 2E, lanes 1 and 2). This product was also observed
in the pellet fraction in the presence of anti-Rev antibodies
(Fig. 2E, lane 3), but not in the pellet fraction in the presence of
anti-GFP antibodies (Fig. 2E, lane 4) or in the absence of antibodies
(Fig. 2E, lane 5).
3.2. The arginine-rich region of Rev binds speciﬁcally to HCV 50-UTR
RNA
Labeled 50-UTR RNA (nt 1–340) was incubated with puriﬁed Rev
protein at different concentrations (0.05–0.25 lM). An electropho-
retic mobility shift assay (EMSA) showed that a protein-RNA com-
plex formed in the presence of Rev protein (Fig. 3A, lane 2), and
that the intensity of the complex increased as the concentration
of Rev increased (Fig. 3A, lanes 2–4).
We next assessed the binding speciﬁcity of Rev to HCV 50-UTR
RNA. First, we analyzed and compared the binding abilities of
Rev, Rev-M6, Rev-M10, and bovine serum albumin (BSA) to HCV
50-UTR RNA. A protein-RNA complex did not form in the presence
of BSA (Fig. 3B, lane 5). Wild-type Rev and Rev-M10 bound the HCV
50-UTR RNA (Fig. 3B, lanes 2 and 4), but the binding activity of the
Rev-M6 mutant to HCV 50-UTR RNA was signiﬁcantly reduced
(Fig. 3B, lane 3).
Second, the binding ability of Rev to the HCV 50-UTR was
evaluated using a competitive EMSA. Unlabeled HCV 50-UTR RNA
competed for the interaction of Rev with the HCV 50-UTR
(Fig. 3C, lanes 3 and 4). Unlabeled HIV-1 RRE RNA also competed
with Rev (Fig. 3C, lanes 5 and 6), but GFP mRNA, which served as
a negative control, did not affect the interaction (Fig. 3C, lanes 7
and 8).
3.3. Rev binds speciﬁcally to the ﬁrst internal loop (IIIb) of HCV 50-UTR
RNA
To identify the Rev binding region in HCV 50-UTR RNA, we gen-
erated two shorter HCV 50-UTR RNA fragments A1–120 (nt 1–120)
and A1–290 (nt 1–290) (Figs. 1 and 4A, right panels). Our EMSA re-
sults showed that a protein-RNA complex formed in the presence
Fig. 2. Rev enhances HCV gene expression. (A) Huh7.5.1 cells were cotransfected with FL-J6/JFH-50C19Rluc2AUbi RNA (0.1 lg) and HIV gene mRNAs (0.3 lg each) or GFP
mRNA (0.3 lg). Renilla luciferase activity was then measured in the transfected cells. (B) Huh7.5.1 cells were cotransfected with FL-J6/JFH-50C19Rluc2AUbi RNA and mRNA
encoding Rev, Rev-M6, Rev-M10, or GFP. (C) Huh7.5.1 cells were cotransfected with FL-J6/JFH-50C19Rluc2AUbi RNA (0.1 lg) and the plasmid PNL4-3 (0.3 lg) or pUC18
(0.3 lg). (D) Huh7.5.1 cells were infected with JFH1 (MOI = 0.01) for 4 days, and then transfected with mRNA encoding Rev, Rev-M6, Rev-M10, or GFP (1.5 lg each) for 48 h.
HCV core, HIV-1 Rev, and b-actin were detected by Western blotting with speciﬁc antibodies. (E) The binding ability of Rev to HCV RNA was determined by in vivo
immunoprecipitation. Coimmunoprecipitated HCV RNA was detected by RT-PCR. Abbreviation: Sup., supernatant.
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tant HCV 50-UTR RNA (A1–290⁄) (Fig. 4A, lanes 2 and 4). However, a
protein-RNA complex did not form in the presence of Rev and
labeled mutant HCV 50-UTR RNA (A1–120⁄) (Fig. 4A, lane 6).
To conﬁrm the Rev binding region in HCV 50-UTR RNA, we gen-
erated a series of HCV 50-UTR RNA deletion mutants. Mutant A1 (nt
189–206 were deleted) was generated by deleting the terminal
loop (IIIb). Mutant A2 (nt 176–221 were deleted) was created by
further truncating the ﬁrst internal loop in domain III. Mutant A3
(nt 144–245 were deleted) was constructed by removing loopsIIIa–c (Figs. 1 and 4B, right panels). All deletion mutants introduce
a GAAA sequence at the tip of the truncation as described previ-
ously [22]. Our EMSA results showed that a protein-RNA complex
formed in the presence of Rev and wild-type HCV 50-UTR RNA (A⁄)
or mutant A1⁄ (Fig. 4B, lanes 2 and 4), but not with mutant A2⁄ or
A3⁄ (Fig. 4B, lanes 6 and 8).
To conﬁrm that the binding site for Rev is located in the ﬁrst
internal loop (IIIb) of the HCV 50-UTR, two additional mutants were
constructed (Figs. 1 and 4C, right panels). We constructed mutant
A4, in which two amino acids (A214 and G216) were deleted, and
Fig. 3. Binding of Rev to HCV 50-UTR RNA by EMSA. (A) Labeled HCV 50-UTR RNA (nt 1–340) (0.1 lg) was incubated with puriﬁed Rev (0–0.25 lM). The protein-RNA complex
was separated from free RNA and examined by an EMSA. (B) Labeled HCV 50-UTR RNA (lanes 1–6) was incubated with DMSO (lane 1), Rev (lane 2), Rev-M6 (lane 3), Rev-M10
(lane 4), or BSA (lane 5). (C) Labeled HCV 50-UTR RNA (lanes 1–8) was incubated with DMSO (lane 1) or Rev (lanes 2–8) in the presence of a 10- or 100-fold molar excess of
unlabeled competitor RNA: A (lanes 3 and 4), HIV-1 RRE RNA (lanes 5 and 6), and GFP mRNA (lanes 7 and 8). A⁄ indicates labeled HCV 50-UTR RNA; A indicates unlabeled
competitor HCV 50-UTR RNA.
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and U215) were substituted by ﬁve purines (G). EMSA revealed
that a protein-RNA complex formed in the presence of Rev and
the wild-type (A⁄) or mutant HCV 50-UTR (A5⁄) (Fig. 4C, lanes 2
and 6), but not with mutant A4⁄ (Fig. 4C, lane 4). In addition, in
the presence of mutant A5⁄, the intensity of the complex was
reduced (Fig. 4C, lane 6 vs. lane 2).
3.4. Rev binds within the HCV 50-UTR and activates HCV IRES RNA
translation
To analyze the role of Rev in the regulation of HCV IRES-medi-
ated translation, we generated three monocistronic reporters, HCV
50-Luc-30, HCV 50-Luc, and HCV Luc-30 (Fig. 5A). Huh7.5.1 cells were
co-transfected with RNA encoding HCV 50-Luc-30, HCV 50-Luc, or
HCV Luc-30 and mRNAs encoding Rev, Rev-M6, Rev-M10, or GFP,respectively. Cells were collected and the lysates were used for
luciferase activity assays. To determine the effect of Rev on HCV
IRES-mediated translation, the translation of the three RNAs was
set to 1 in the GFP mRNA-transfected cells. The HCV 50-Luc-30,
HCV 50-Luc, and HCV Luc-30 RNAs were not translated in the pres-
ence of GFP, Rev-M6, and Rev-M10 (Fig. 5B). In the presence of Rev,
translation of the HCV 50-Luc-30 and HCV 50-Luc RNAs was signiﬁ-
cantly stimulated; however, there was no translational activity of
HCV Luc-30 RNA (Fig. 5B).
To investigate the role of loop IIIb in the activation of HCV IRES-
mediated translation regulated by Rev, two HCV 50-Luc-30 mutants
were generated: HCV 50-Luc-30 A4, which contained two adenine
deletions within internal loop IIIb of the HCV 50-UTR, and HCV 50-
Luc-30 A5, which carried ﬁve guanine-to-adenine nucleotide substi-
tutions within internal loop IIIb of the HCV 50-UTR. Huh7.5.1 cells
were co-transfected with HCV 50-Luc-30 A4 or HCV 50-Luc-30 A5
Fig. 4. Effects of mutations in the HCV 50-UTR on the binding of Rev. (A) Effect of truncations in the HCV 50-UTR on Rev binding. (B) Effect of sequential deletions in domain III
of the HCV 50-UTR on Rev binding. (C) Effect of mutations in internal loop IIIb of the HCV 50-UTR on Rev binding.
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RNAs was set to 1 in the GFP mRNA-transfected cells. In the pres-
ence of Rev, the translation of HCV 50-Luc-30 RNA was signiﬁcantly
enhanced, while there was no translation of HCV 50-Luc-30 A4 RNA
(Fig. 5C). In addition, Rev activated the translation of HCV 50-Luc-30
A5 RNA, although the level of translation was reduced (Fig. 5C).4. Discussion
In this study, we demonstrated that HIV-1 Rev protein stimu-
lated HCV gene expression. Rev interacts with both HIV-1 RNA
andwith the RNAs of heterogenetic viruses. For example, Revmedi-
ates nuclear export through the Rec/cORF-responsive element, an
4008 J. Qu et al. / FEBS Letters 585 (2011) 4002–4009RRE functional homolog in the 30-LTR of the human endogenous ret-
rovirus HERV-K [23]. In addition, Rev heterologously promotes
expression of the simple beta retrovirus mouse mammary tumor
virus (MMTV) and binds directly to RNA in the U3 region [24,25].
Our immunoprecipitation results demonstrate that Rev can bind
to HCV RNAs.
An EMSA showed that Rev binds directly to HCV 50-UTR RNA
and that the arginine-rich 41-44 amino acid region of Rev contrib-
utes to this binding activity. We generated a series HCV 50-UTR
truncation mutants and analyzed their interactions with Rev. We
found that domains IIIa–d of the 50-UTR were crucial for Rev bind-
ing. The three-dimensional structure of loop A in the HIV-1 50-UTR
can be directly superimposed onto that of the HIV-1 RRE internal
loop (Rev-binding site) [26], and loop A is also a Rev-binding site
(Fig. 1B) [27]. The three-dimensional structure of loop IIIb in HCV
is very similar to the RRE internal loop in HIV-1 [28] and loop A
in the HIV-1 50-UTR [26]. Based on this information, we examined
whether Rev binds to loop IIIb in the HCV 50-UTR. Using HCV 50-
UTR deletion mutants, we showed that Rev binds speciﬁcally to
this region. This suggests that the nucleotide-amino acid interac-
tions involved in the binding of Rev and internal loop IIIb areFig. 5. Rev regulates translation mediated by the HCV 50-UTR. (A) Schematic diagram of
complete HCV 50-UTR (nt 1–340); C: 25 amino acids of the core protein-encoding sequen
HCV 30-UTR. (B) Rev increases translation mediated by the HCV 50-UTR. (C) Internal loop
Rev.analogous to those identiﬁed previously in the Rev-RRE or Rev-
loop A complex.
In our study, we evaluated the function of Rev in translation
mediated by HCV IRES. Consistent with an enhanced polysomal
association of RRE-containing RNAs, Rev may also regulate the
translation of HIV-1 RNA [11,29]. It is believed that Rev plays a
direct role in HIV-1 RNA translation [30]. Employing monocistronic
HCV reporter RNAs, we found that Rev speciﬁcally stimulated
translation mediated by the HCV IRES. Loop A in the HIV-1 50-
UTR is known to speciﬁcally bind Rev [27], and it is believed to play
a role in the Rev-mediated stimulation of translation [11]. We
demonstrated that Rev binds directly to loop IIIb in the HCV 50-
UTR. We next investigated the role of this binding site in the acti-
vation of HCV IRES-mediated translation regulated by HIV-1 Rev.
We found that Rev stimulated the translation of HCV RNAs. Also,
this stimulatory activity was dependent on an intact internal loop
(IIIb) in the HCV 50-UTR. Thus, we conclude that Rev, by binding to
the HCV 50-UTR, enhances HCV IRES-mediated translation.
The mechanism of Rev binding to the HCV 50-UTR and the
activation of translation mediated by HCV IRES is not well charac-
terized. However, Rev is known to enhance the association ofthe HCV 50-Luc-30 , HCV 50-Luc, and HCV Luc-30 RNAs. T7: T7 promoter; 50UTR: the
ce from strain HCV-2a; Ub: ubiquitin; FLuc: ﬁreﬂy luciferase gene; 30 UTR: the entire
IIIb is involved in the activation of HCV 50-UTR-mediated translation regulated by
J. Qu et al. / FEBS Letters 585 (2011) 4002–4009 4009Rev-dependent viral RNA with polysomes [31]. It is possible that
the binding of Rev to internal loop IIIb acts as a signal that initiates
HCV RNA recognition by the translational machinery. The IRES of
HCV drives translation by directly recruiting 40S ribosomal subunit
and binds to eIF3. Rev may enhance HCV IRES-mediated transla-
tion by recruiting components involved in the initiation of transla-
tion, including the 40S ribosomal subunit and eIF3. In addition, Rev
dramatically stabilizes RRE-containing HIV-1 RNA transcripts in
the nucleus [32]. The interaction between Rev and the HCV 50-
UTR may stabilize the IRES secondary structure of HCV, which
facilitates the translation initiation complex assembly.
In summary, this study is the ﬁrst to demonstrate that HIV-1
Rev binds directly to the HCV 50-UTR and stimulates HCV gene
expression. In addition, we found that the binding site for Rev is lo-
cated in internal loop IIIb of the HCV 50-UTR. These results provide
insight into the coinfection of HIV-1 and HCV.
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